Assessment of PFT, Safety, and PK of Zileuton Injection in Asthma Patients
- First Posted Date
- 2007-09-26
- Last Posted Date
- 2008-03-21
- Lead Sponsor
- Critical Therapeutics
- Target Recruit Count
- 36
- Registration Number
- NCT00534625
Zileuton CR vs Placebo in Poorly Controlled Asthma Patients on Moderate Dose ICS
- First Posted Date
- 2007-06-14
- Last Posted Date
- 2008-04-03
- Lead Sponsor
- Critical Therapeutics
- Target Recruit Count
- 400
- Registration Number
- NCT00486343
- Locations
- ๐บ๐ธ
Critical Therapeutics, Lexington, Massachusetts, United States
Safety Study of Zileuton Injection in Patients With Asthma
Phase 1
Completed
- Conditions
- Asthma
- First Posted Date
- 2006-03-06
- Last Posted Date
- 2007-09-26
- Lead Sponsor
- Critical Therapeutics
- Target Recruit Count
- 60
- Registration Number
- NCT00299065
- Locations
- ๐บ๐ธ
Allergy & Asthma Specialist Medical Group, Huntington Beach, California, United States
๐บ๐ธAllergy and Asthma Medical Group and Research Center, San Diego, California, United States
๐บ๐ธColorado Allergy and Asthma Centers, PC, Englewood, Colorado, United States
CTI-01 (Ethyl Pyruvate) Safety and Complication Prevention in Cardiac Surgery Patients on Cardiopulmonary Bypass (CPB)
Phase 2
Terminated
- Conditions
- Heart Valve DiseasesCoronary Disease
- First Posted Date
- 2005-04-07
- Last Posted Date
- 2006-03-17
- Lead Sponsor
- Critical Therapeutics
- Target Recruit Count
- 150
- Registration Number
- NCT00107666
- Locations
- ๐บ๐ธ
Saddleback Memorial Medical Center, Laguna Hills, California, United States
๐บ๐ธUniversity of Southern California, Los Angeles, California, United States
๐บ๐ธKaiser Permanente, San Francisco, California, United States
Study of Oral Zileuton in the Treatment of Moderate to Severe Facial Acne Vulgaris
Phase 2
- Conditions
- Acne Vulgaris
- First Posted Date
- 2004-12-08
- Last Posted Date
- 2007-02-07
- Lead Sponsor
- Critical Therapeutics
- Target Recruit Count
- 90
- Registration Number
- NCT00098358
- Locations
- ๐บ๐ธ
Therapeutics Clinical Research, San Diego, California, United States
๐บ๐ธMedaPhase, Inc., Newnan, Georgia, United States
๐บ๐ธDermatology Specialists, PSC, Louisville, Kentucky, United States